sitagliptin glp 1 agonist How do SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors compare in reducing #mortality and #cardiovascular events in patients with type 2 #diabetes? Find out Mechanism of action of GLP-1
Description
Type 2 diabetes affects over 500 million people globally
This process includes checking for a personal or family history of multiple endocrine neoplasia syndrome type 2 or medullary thyroid carcinoma
Berlin-Chemie and Roche (speakers bureau)
Hazard ratios (HR) were adjusted for confounders, providing a robust estimate of associations
Research on rebound weight gain after discontinuation of GLP-1 drugs shows that many users regain weight within a timeframe similar to their usage period
J., Waller, P
